Want to join the conversation?
Specialty biopharma company $EBS said that its military-grade auto-injector platform, Emergard, has been selected by the US DoD and the Battelle Memorial Institute to be tested against and developed to US military specifications as a platform for nerve agent antidote delivery. Emergard development and testing is expected to be completed in 2016.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.